Dronedarone: Current evidence and future questions

Cardiovascular Therapeutics

Volumn 28, Issue 1, 2010, Pages 38-47

  Schafer, Jeremy A ^a   Kjesbo, Nicole K ^a   Gleason, Patrick P ^a  

^a Prime Therapeutics   (United States)

Author keywords

Amiodarone; ATHENA; Atrial fibrillation; Dronedarone

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; ANTIDEPRESSANT AGENT; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLARITHROMYCIN; CYTOCHROME P450 3A4; DIGITALIS; DIGOXIN; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DRONEDARONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; KETOCONAZOLE; MEVINOLIN; MULTAQ; PLACEBO; PROPRANOLOL; SIMVASTATIN; SPIRONOLACTONE; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG; VERAPAMIL; WARFARIN;

ANTIARRHYTHMIC ACTIVITY; BLEEDING; CLINICAL TRIAL; DIARRHEA; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CONTRAINDICATION; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG ELIMINATION; DRUG EXCRETION; DRUG FATALITY; DRUG HALF LIFE; DRUG METABOLISM; DRUG PROTEIN BINDING; DRUG SAFETY; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FOOD AND DRUG ADMINISTRATION; GASTROINTESTINAL DISEASE; GRAPEFRUIT JUICE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART FAILURE; HOSPITALIZATION; HUMAN; HYPOTHYROIDISM; LONG TERM CARE; LUNG DISEASE; LUNG TOXICITY; MEDLINE; MYOTONIC DYSTROPHY; NAUSEA; PRIORITY JOURNAL; QT INTERVAL; QT PROLONGATION; RASH; RECURRENT DISEASE; REVIEW; SIDE EFFECT; SINUS RHYTHM; SLEEP DISORDER; SUDDEN DEATH; THYROID FUNCTION TEST; TORSADE DES POINTES; TREATMENT DURATION; TREMOR;

AMIODARONE; ANIMALS; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CLINICAL TRIALS, PHASE III AS TOPIC; DRUG INTERACTIONS; EVIDENCE-BASED MEDICINE; HUMANS; PATIENT SELECTION; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 74549216393     PISSN: 17555914     EISSN: 17555922     Source Type: Journal    
DOI: 10.1111/j.1755-5922.2009.00112.x     Document Type: Review

References (30)

1. Fuster V, Rydén LE, Cannom DS, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: Executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) [published correction appears in J Am Coll Cardiol. 2007;50:562[. J Am Coll Cardiol 2006 48 : 854 906. (Pubitemid 44175743)
2. Lloyd-Jones D, Adams R, Carnethon M, et al. Heart disease and stroke statistics - 2009 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009 119 : 480 486.
3. Friberg J, Buch P, Scharling H, Gadsbphioll N, Jensen GB. Rising rates of hospital admissions for atrial fibrillation. Epidemiology 2003 14 : 666 672.
4. Miyasaka Y, Barnes ME, Gersh BJ, et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 2006 114 : 119 125.
5. Coyne KS, Paramore C, Grandy S, Mercader M, Reynolds M, Zimetbaum P. Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States. Value Health 2006 9 : 348 356.
6. Dale KM, White CM. Dronedarone: An amiodarone analog for the treatment of atrial fibrillation and atrial flutter. Ann Pharmacotherapy 2007 41 : 599 605.
7. Center for Drug Evalution and Research. Cordarone (amiodarone) prescribing information [Online[. April 21, 2009 [cited July 15, 2009[. Available from: URL : http://www.accessdata.fda.gov/drugsatfda-docs/label/2009/ 018972s038s039lbl.pdf
8. Center for Drug Evaluation and Research. Briefing information for the March 18, 2009 meeting of the Cardiovascular and Renal Drugs Advisory Committee [Online[. February 19, 2009 [cited July 15, 2009[. Available from: URL : http://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ CardiovascularandRenalDrugsAdvisoryCommittee/ucm134972.htm
9. Zimetbaum PJ. Dronedarone for atrial fibrillation - an odyssey. N Engl J Med 2009 18 : 1811 1813.
10. Center for Drug Evalution and Research. Multaq (dronedarone) prescribing information [Online[. July 1, 2009 [cited July 15, 2009[. Available from: URL : http://www.accessdata.fda.gov/drugsatfda-docs/label/2009/022425lbl.pdf
11. Podrid PJ. Amiodarone: Reevaluation of an old drug. Ann Intern Med 1995 122 : 689 700.
12. Touboul P, Brugada J, Capucci A, Crijns HJ, Edvardsson N, Hohnloser SH. Dronedarone for prevention of atrial fibrillation: A dose-ranging study. Eur Heart J 2003 24 : 1481 1487.
13. Tschuppert Y, Buclin T, Rothuizen LE, Decosterd LA, Galleyrand J, Gaud C, Biollaz J. Effect of dronedarone on renal function in healthy subjects. Br J Clin Pharmacol 2007 64 : 785 791.
14. Klotz U. Antiarrhythmics elimination and dosage considerations in hepatic impairment. Clin Pharmacokinet 2007 46 : 985 996.
15. Hohnloser SH, Crijns HJ, van Eickels M, et al. Effect of dronedarone on cardiovascular events in atrial fibrillation. N Engl J Med 2009 360 : 668 678.
16. Davy JM, Herold M, Hoglund C, et al. Dronedarone for the control of ventricular rate in permanent atrial fibrillation: The efficacy and safety of dronedarone for the control of ventricular rate during atrial fibrillation (ERATO) study. Am Heart J 2008 156 : 527e1 527e9.
17. Singh BN, Connolly SJ, Crijns HJ, et al. Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter. N Engl J Med 2007 357 : 987 999.
18. ClinicalTrials.gov. Efficacy and safety of dronedarone versus amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation (DIONYSIS) [Online[. March 16, 2009 [cited July 15, 2009[; Available from: URL : http://www.clinicaltrials.gov/ct2/show/NCT00489736?term=dronedarone&rank=5
19. Kober L, Torp-Pedersen C, McMurray JJ, et al. Increased mortality after dronedarone therapy for severe heart failure. N Engl J Med 2008 358 : 2678 2687.
20. Sanofi-Aventis. Multaq (dronedarone) FDA Caridovascular and Renal Drugs Division Advisory Committee Meeting presentation [Online[. March 18, 2009 [cited July 15, 2009[; Available from: URL : http://www.fda.gov/downloads/ AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ CardiovascularandRenalDrugsAdvisoryCommittee/UCM136957.pdf
21. Howard PA. Dronedarone: Emergence of a new therapeutic option for the treatment of atrial fibrillation. Hospital Pharm 2009 44 : 562 568.
22. Kalus JS. Pharmacologic management of atrial fibrillation: Established and emerging options. J Manag Care Pharm 2009 15 (6-b Suppl S10 S18.
23. Center for Drug Evaluation and Research. Summary minutes of the Cardiovascular and Renal Drugs Advisory Committee March 18, 2009 [Online[. March 18, 2009 [cited July 15, 2009[; Available from: URL : http://www.fda.gov/ downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ CardiovascularandRenalDrugsAdvisoryCommittee/UCM151691.pdf
24. Nieuwlaat R, Eurlings LW, Cleland JG, et al. Atrial fibrillation and heart failure in cardiology practice: Reciprocal impact and combined management from the perspective of atrial fibrillation. J Am Coll Cardiol 2009 53 : 1690 1698.
25. Roy D, Talajic M, Nattel S, et al. Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med 2008 358 : 2667 2677.
26. Torp-Pedersen C, Moller M, Bloch-Thomsen PE, et al. Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group. N Engl J Med 1999 341 : 857 865.
27. Singh SN, Fletcher RD, Fisher SG, et al. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. N Engl J Med 1995 333 : 77 82.
28. Middlekauff HR, Wiener I, Saxon LA, Stevenson WG. Low-dose amiodarone for atrial fibrillation: Time for a prospective study? Ann Intern Med 1992 116 : 1017 1020.
29. Piccini JP, Hasselblad V, Peterson ED, Washam JB, Califf RM, Kong DF. Comparative efficacy of droneadarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation. J Am Coll Cardiol 2009 54 : 1089 1095.
30. Wyse DG, Waldo AL, DiMarco JP, et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002 347 : 1825 1833.